National Primary Health Care Development Agency, Nigeria.
World Health Organization Country Office Nigeria, Nigeria.
Vaccine. 2021 Nov 17;39 Suppl 3:C82-C88. doi: 10.1016/j.vaccine.2021.02.067. Epub 2021 Mar 11.
An Adverse event following immunization (AEFI) is an untoward medical occurrence following immunization and which may not have a necessary causal relationship with the usage of a vaccine. The World Health Organization categories AEFI into two; serious and non-serious. An AEFI is considered serious if it is life-threatening, requires inpatient hospitalization or results in death. The measles vaccine is safe and effective however because it is a live-attenuated injectable vaccine it is more prone to AEFI as compared to non-injectable vaccines when given in large numbers over a short period as is the nature of measles mass vaccination campaigns (MVC). This article describes Nigeria's experience on AEFI reporting during the 2017/2018 Measles vaccination campaign (MVC).
We reviewed various materials which included the Open Data Kit (ODK) which is an open source smartphone-based data collecting tool, operations room reports, measles campaign tally sheets, AEFI line listing forms, the post measles campaign coverage survey report and the report of the AEFI national expert committee review of the 2017/2018 Nigeria measles MVC.
A total of 6,214 suspected cases of AEFI were line listed from all 36 states and the Federal Capital Territory(FCT) during the 2017/2018 MVC with Fever(38%) and pain at injection site the (30%)most common reports. Overall, 99.7% AEFIs were reported to be non-serious AEFIs, with almost all cases resolved fully with no long-term sequalae.. The national incidence of suspected AEFI per 100,000 population was 16.3 with subnational incidence highest in Kebbi state (101.3/100,000) and lowest in Bayelsa state (0.8/100,000).
Adequate AEFI reporting, Investigation and management remains important in managing the risk of a disruption of mass campaigns. The deployment of supervisors during campaign may play an important role in improving the identification and reporting of suspected AEFI. Further inquiries about AEFIs during the post campaign coverage evaluation also played a role in improving AEFI reporting and documentation. The real-time, on the spot, follow up by the national operations team helped with decision making and intervention including AEFI investigations and assessments.
疫苗不良反应(AEFI)是指接种疫苗后发生的不良医学事件,且不一定与疫苗使用有必然因果关系。世界卫生组织将 AEFI 分为两类:严重和非严重。如果 AEFI 危及生命、需要住院治疗或导致死亡,则被认为是严重的。麻疹疫苗是安全有效的,然而,由于它是一种减毒活的注射用疫苗,与非注射用疫苗相比,在短时间内大量接种时更容易出现 AEFI,就像麻疹大规模疫苗接种运动(MVC)的性质一样。本文描述了尼日利亚在 2017/2018 年麻疹疫苗接种运动(MVC)期间报告 AEFI 的经验。
我们回顾了各种材料,包括基于开放源智能手机的数据收集工具 Open Data Kit(ODK)、作战室报告、麻疹运动计数表、AEFI 列表表单、麻疹运动后覆盖调查报告以及 2017/2018 年尼日利亚麻疹 MVC 国家专家委员会对 AEFI 的审查报告。
在 2017/2018 年 MVC 期间,从 36 个州和联邦首都区(FCT)共列出了 6214 例疑似 AEFI,发热(38%)和注射部位疼痛(30%)是最常见的报告。总体而言,99.7%的 AEFI 报告为非严重 AEFI,几乎所有病例均完全解决,无长期后遗症。全国疑似 AEFI 每 10 万人发病率为 16.3,州级发病率以凯比州最高(101.3/100,000),以巴耶尔萨州最低(0.8/100,000)。
充分报告、调查和管理 AEFI 对于管理大规模运动中断的风险仍然很重要。在运动期间部署监督员可能在识别和报告疑似 AEFI 方面发挥重要作用。在运动后覆盖评估期间进一步调查 AEFI 也有助于提高 AEFI 报告和文件记录。国家行动小组的实时现场跟进有助于决策和干预,包括 AEFI 调查和评估。